A5081214299- Urinary Bladder and Prostate Research
- Prostate Cancer Diagnosis and Treatment
- Hormonal and reproductive studies
- Pelvic floor disorders treatments
- Particle physics theoretical and experimental studies
- Urological Disorders and Treatments
- Urologic and reproductive health conditions
- High-Energy Particle Collisions Research
- Sexual function and dysfunction studies
- Quantum Chromodynamics and Particle Interactions
- Urinary Tract Infections Management
- Prostate Cancer Treatment and Research
- Computational Physics and Python Applications
- Pharmacology and Obesity Treatment
- Sexual Differentiation and Disorders
- Particle Detector Development and Performance
- Cardiovascular Syncope and Autonomic Disorders
- Bladder and Urothelial Cancer Treatments
- Healthcare Policy and Management
- Pediatric Urology and Nephrology Studies
- Connexins and lens biology
- Genital Health and Disease
- Health Systems, Economic Evaluations, Quality of Life
- Private Equity and Venture Capital
- Kidney Stones and Urolithiasis Treatments
Icahn School of Medicine at Mount Sinai
2016-2025
Mount Sinai Health System
2015-2025
Mount Sinai Hospital
2016-2024
Mount Sinai Hospital
2020-2024
Aventura Hospital and Medical Center
2021-2023
National Bureau of Economic Research
1991-2023
Cornell University
2008-2023
Southwestern Medical Center
2023
Presbyterian Hospital
2008-2023
The University of Texas Southwestern Medical Center
1996-2023
Benign prostatic hyperplasia is commonly treated with alpha-adrenergic-receptor antagonists (alpha-blockers) or 5alpha-reductase inhibitors. The long-term effect of these drugs, singly combined, on the risk clinical progression unknown.We conducted a long-term, double-blind trial (mean follow-up, 4.5 years) involving 3047 men to compare effects placebo, doxazosin, finasteride, and combination therapy measures benign hyperplasia.The overall progression--defined as an increase above base line...
To revise the 2003 version of American Urological Association's (AUA) Guideline on management benign prostatic hyperplasia (BPH).From MEDLINE® searches English language publications (January 1999 through February 2008) using relevant MeSH terms, articles concerning index patient, a male ≥45 years age who is consulting healthcare provider for lower urinary tract symptoms (LUTS) were identified. Qualitative analysis evidence was performed. Selected studies stratified by design, comparator,...
Isolated prostate specific antigen (PSA) determinations in asymptomatic individuals have not demonstrated sufficient sensitivity and specificity to be useful the routine evaluation of disease. To enhance accuracy serum PSA we used a quotient volume, which refer as density (PSAD). Prostate volume this study was calculated from magnetic resonance imaging benign prostatic hypertrophy (BPH) or dimensions surgical specimen cancer using formula, length x width depth 0.5 = volume. A total 61...
Men with overactive bladder and other lower urinary tract symptoms may not respond to monotherapy antimuscarinic agents or alpha-receptor antagonists.To evaluate the efficacy safety of tolterodine extended release (ER), tamsulosin, both in men who met research criteria for benign prostatic hyperplasia.Randomized, double-blind, placebo-controlled trial conducted at 95 urology clinics United States involving 40 years older had a total International Prostate Symptom Score 12 higher and, an...
You have accessJournal of UrologyAdult Urology1 Sep 2018Surgical Management Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Harris E. Foster, Michael J. Barry, Philipp Dahm, Manhar C. Gandhi, Steven A. Kaplan, Tobias S. Kohler, Lori B. Lerner, Deborah Lightner, Kellogg Parsons, Claus G. Roehrborn, Charles Welliver, Timothy Wilt, and Kevin T. McVary FosterHarris Foster , BarryMichael Barry DahmPhilipp Dahm GandhiManhar Gandhi KaplanSteven Kaplan...
Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing proliferation of smooth muscle and epithelial cells within the transition zone. The prevalence severity lower urinary tract symptoms (LUTS) in aging men are progressive impact health welfare society. This revised Guideline provides useful reference on effective evidence-based management male LUTS/BPH. See accompanying algorithm for summary procedures detailed (figures 1 2[Figure: see text][Figure: text]).The Minnesota...
You have accessJournal of UrologyAUA Guideline Article1 Oct 2021Management Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II—Surgical Evaluation and Treatmentis corrected byManagement Treatment. Erratumis I—Initial Work-up Medical Management. Erratum Lori B. Lerner, MD Kevin T. McVary, Michael J. Barry, Brooke R. Bixler, MPH Philipp Dahm, Anurag Kumar Das, Manhar C. Gandhi, Steven A. Kaplan, Tobias S. Kohler, Leslie Martin, Kellogg Parsons, Claus...
No AccessJournal of UrologyClinical Urology: Original Article1 Feb 1995Urodynamic Findings in Patients With Diabetic Cystopathy Steven A. Kaplan, Alexis E. Te, Jerry G. Blaivas, and Edward J. McGuire KaplanSteven Kaplan , TeAlexis Te BlaivasJerry Blaivas McGuireEdward View All Author Informationhttps://doi.org/10.1097/00005392-199502000-00013AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail To ascertain the...
No AccessJournal of UrologyUrological Neurology and Urodynamics1 Apr 1991Bladder Outlet Obstruction versus Impaired Detrusor Contractility: The Role Uroflow Michael B. Chancellor, Jerry G. Blaivas, Steven A. Kaplan, Sheldon Axelrod ChancellorMichael Chancellor , BlaivasJerry Blaivas KaplanSteven Kaplan AxelrodSheldon View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)38458-6AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked...
Prostate volume has been poorly correlated to various parameters used assess benign prostatic hyperplasia (BPH), including symptoms, peak urine flow and detrusor pressure at flow. The purpose of this study was 2-fold: 1) determine if transrectal ultrasound measurement the transition zone prostate served as a better proxy for determining size with American Urological Association symptom score, pressure, 2) parameter index (the ratio between volume) useful in evaluating clinical prostatism.We...
We examined pooled baseline data from 2 lipid treatment studies to evaluate the relationship among total serum testosterone levels, obesity and metabolic syndrome in aging men.Baseline testosterone, lipid, glycemic anthropometric were obtained 864 men (mean age 52 years) participating studies. Inclusion criteria for included low-density lipoprotein cholesterol 130 160 mg/dl triglycerides 350 or less.For all patients as well nonmetabolic cohorts, decreased with increasing body mass index (p <...
Participation in Internet gambling is growing rapidly, as concern about its possible effects on the public's health. This article reports results of first prospective longitudinal study actual casino behaviour.Data include 2 years recorded betting activity by a cohort gamblers who subscribed to an service during February 2005. We examined computer records each transaction and transformed them into measures involvement. The sample included 4222 played games.The median behaviour was play games...
No AccessJournal of UrologyUrological Survey24 May 2024Benign Prostatic Hyperplasia Steven A. KaplanMD KaplanSteven Kaplan https://orcid.org/0000-0003-2558-7306 View All Author Informationhttps://doi.org/10.1097/JU.0000000000003951AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Advertisement Copyright & Permissions© Inc.Metrics...